Pre-ICU statin therapy reduces 28-day mortality in sepsis-associated brain dysfunction: a propensity-matched analysis of potential neuroprotective mechanisms

Pre-ICU statin therapy was associated with improved 28-day survival in SABD patients, potentially attributable to anti-inflammatory and antioxidant mechanisms. Despite limitations inherent in its retrospective design, this study suggests that statins may represent a promising therapeutic option for SABD patients. Prospective randomized controlled trials are warranted to validate these findings and optimize treatment protocols for this vulnerable population.